Report cover image

Children's Antipyretic Medicine Industry Research Report 2025

Publisher APO Research, Inc.
Published Jul 07, 2025
Length 136 Pages
SKU # APRC20260733

Description

Summary

According to APO Research, the global Children's Antipyretic Medicine market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Children's Antipyretic Medicine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Children's Antipyretic Medicine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Children's Antipyretic Medicine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Children's Antipyretic Medicine include Zhejiang Kangle, Xinhua Pharmaceutical, Hebei Jiheng, Changshu Huagang, Anhui Fubore, Anhui BBCA Likang, Temad, Strides Shasun and SKPL, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Children's Antipyretic Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Children's Antipyretic Medicine.

The report will help the Children's Antipyretic Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Children's Antipyretic Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Children's Antipyretic Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Children's Antipyretic Medicine Segment by Company

Zhejiang Kangle
Xinhua Pharmaceutical
Hebei Jiheng
Changshu Huagang
Anhui Fubore
Anhui BBCA Likang
Temad
Strides Shasun
SKPL
Novacyl
Mallinckrodt
IOLCP
Granules India
Granules Biocause
Farmson
Atabay
Anqiu Lu'an
Children's Antipyretic Medicine Segment by Type

Ibuprofen
Acetaminophen
Other
Children's Antipyretic Medicine Segment by Application

Online Sales
Offline Sales
Children's Antipyretic Medicine Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Children's Antipyretic Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Children's Antipyretic Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Children's Antipyretic Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Children's Antipyretic Medicine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Children's Antipyretic Medicine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Children's Antipyretic Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

136 Pages
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Children's Antipyretic Medicine Market Size (2020-2031)
2.2.2 Global Children's Antipyretic Medicine Sales (2020-2031)
2.2.3 Global Children's Antipyretic Medicine Market Average Price (2020-2031)
2.3 Children's Antipyretic Medicine by Type
2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 Ibuprofen
2.3.3 Acetaminophen
2.3.4 Other
2.4 Children's Antipyretic Medicine by Application
2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.4.2 Online Sales
2.4.3 Offline Sales
3 Market Competitive Landscape by Manufacturers
3.1 Global Children's Antipyretic Medicine Market Competitive Situation by Manufacturers (2020 Versus 2024)
3.2 Global Children's Antipyretic Medicine Sales (K Units) of Manufacturers (2020-2025)
3.3 Global Children's Antipyretic Medicine Revenue of Manufacturers (2020-2025)
3.4 Global Children's Antipyretic Medicine Average Price by Manufacturers (2020-2025)
3.5 Global Children's Antipyretic Medicine Industry Ranking, 2023 VS 2024 VS 2025
3.6 Global Manufacturers of Children's Antipyretic Medicine, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Children's Antipyretic Medicine, Product Type & Application
3.8 Global Manufacturers of Children's Antipyretic Medicine, Established Date
3.9 Global Children's Antipyretic Medicine Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Zhejiang Kangle
4.1.1 Zhejiang Kangle Company Information
4.1.2 Zhejiang Kangle Business Overview
4.1.3 Zhejiang Kangle Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
4.1.4 Zhejiang Kangle Children's Antipyretic Medicine Product Portfolio
4.1.5 Zhejiang Kangle Recent Developments
4.2 Xinhua Pharmaceutical
4.2.1 Xinhua Pharmaceutical Company Information
4.2.2 Xinhua Pharmaceutical Business Overview
4.2.3 Xinhua Pharmaceutical Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
4.2.4 Xinhua Pharmaceutical Children's Antipyretic Medicine Product Portfolio
4.2.5 Xinhua Pharmaceutical Recent Developments
4.3 Hebei Jiheng
4.3.1 Hebei Jiheng Company Information
4.3.2 Hebei Jiheng Business Overview
4.3.3 Hebei Jiheng Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
4.3.4 Hebei Jiheng Children's Antipyretic Medicine Product Portfolio
4.3.5 Hebei Jiheng Recent Developments
4.4 Changshu Huagang
4.4.1 Changshu Huagang Company Information
4.4.2 Changshu Huagang Business Overview
4.4.3 Changshu Huagang Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
4.4.4 Changshu Huagang Children's Antipyretic Medicine Product Portfolio
4.4.5 Changshu Huagang Recent Developments
4.5 Anhui Fubore
4.5.1 Anhui Fubore Company Information
4.5.2 Anhui Fubore Business Overview
4.5.3 Anhui Fubore Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
4.5.4 Anhui Fubore Children's Antipyretic Medicine Product Portfolio
4.5.5 Anhui Fubore Recent Developments
4.6 Anhui BBCA Likang
4.6.1 Anhui BBCA Likang Company Information
4.6.2 Anhui BBCA Likang Business Overview
4.6.3 Anhui BBCA Likang Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
4.6.4 Anhui BBCA Likang Children's Antipyretic Medicine Product Portfolio
4.6.5 Anhui BBCA Likang Recent Developments
4.7 Temad
4.7.1 Temad Company Information
4.7.2 Temad Business Overview
4.7.3 Temad Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
4.7.4 Temad Children's Antipyretic Medicine Product Portfolio
4.7.5 Temad Recent Developments
4.8 Strides Shasun
4.8.1 Strides Shasun Company Information
4.8.2 Strides Shasun Business Overview
4.8.3 Strides Shasun Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
4.8.4 Strides Shasun Children's Antipyretic Medicine Product Portfolio
4.8.5 Strides Shasun Recent Developments
4.9 SKPL
4.9.1 SKPL Company Information
4.9.2 SKPL Business Overview
4.9.3 SKPL Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
4.9.4 SKPL Children's Antipyretic Medicine Product Portfolio
4.9.5 SKPL Recent Developments
4.10 Novacyl
4.10.1 Novacyl Company Information
4.10.2 Novacyl Business Overview
4.10.3 Novacyl Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
4.10.4 Novacyl Children's Antipyretic Medicine Product Portfolio
4.10.5 Novacyl Recent Developments
4.11 Mallinckrodt
4.11.1 Mallinckrodt Company Information
4.11.2 Mallinckrodt Business Overview
4.11.3 Mallinckrodt Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
4.11.4 Mallinckrodt Children's Antipyretic Medicine Product Portfolio
4.11.5 Mallinckrodt Recent Developments
4.12 IOLCP
4.12.1 IOLCP Company Information
4.12.2 IOLCP Business Overview
4.12.3 IOLCP Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
4.12.4 IOLCP Children's Antipyretic Medicine Product Portfolio
4.12.5 IOLCP Recent Developments
4.13 Granules India
4.13.1 Granules India Company Information
4.13.2 Granules India Business Overview
4.13.3 Granules India Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
4.13.4 Granules India Children's Antipyretic Medicine Product Portfolio
4.13.5 Granules India Recent Developments
4.14 Granules Biocause
4.14.1 Granules Biocause Company Information
4.14.2 Granules Biocause Business Overview
4.14.3 Granules Biocause Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
4.14.4 Granules Biocause Children's Antipyretic Medicine Product Portfolio
4.14.5 Granules Biocause Recent Developments
4.15 Farmson
4.15.1 Farmson Company Information
4.15.2 Farmson Business Overview
4.15.3 Farmson Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
4.15.4 Farmson Children's Antipyretic Medicine Product Portfolio
4.15.5 Farmson Recent Developments
4.16 Atabay
4.16.1 Atabay Company Information
4.16.2 Atabay Business Overview
4.16.3 Atabay Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
4.16.4 Atabay Children's Antipyretic Medicine Product Portfolio
4.16.5 Atabay Recent Developments
4.17 Anqiu Lu'an
4.17.1 Anqiu Lu'an Company Information
4.17.2 Anqiu Lu'an Business Overview
4.17.3 Anqiu Lu'an Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
4.17.4 Anqiu Lu'an Children's Antipyretic Medicine Product Portfolio
4.17.5 Anqiu Lu'an Recent Developments
5 Global Children's Antipyretic Medicine Market Scenario by Region
5.1 Global Children's Antipyretic Medicine Market Size by Region: 2020 VS 2024 VS 2031
5.2 Global Children's Antipyretic Medicine Sales by Region: 2020-2031
5.2.1 Global Children's Antipyretic Medicine Sales by Region: 2020-2025
5.2.2 Global Children's Antipyretic Medicine Sales by Region: 2026-2031
5.3 Global Children's Antipyretic Medicine Revenue by Region: 2020-2031
5.3.1 Global Children's Antipyretic Medicine Revenue by Region: 2020-2025
5.3.2 Global Children's Antipyretic Medicine Revenue by Region: 2026-2031
5.4 North America Children's Antipyretic Medicine Market Facts & Figures by Country
5.4.1 North America Children's Antipyretic Medicine Market Size by Country: 2020 VS 2024 VS 2031
5.4.2 North America Children's Antipyretic Medicine Sales by Country (2020-2031)
5.4.3 North America Children's Antipyretic Medicine Revenue by Country (2020-2031)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Children's Antipyretic Medicine Market Facts & Figures by Country
5.5.1 Europe Children's Antipyretic Medicine Market Size by Country: 2020 VS 2024 VS 2031
5.5.2 Europe Children's Antipyretic Medicine Sales by Country (2020-2031)
5.5.3 Europe Children's Antipyretic Medicine Revenue by Country (2020-2031)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Children's Antipyretic Medicine Market Facts & Figures by Country
5.6.1 Asia Pacific Children's Antipyretic Medicine Market Size by Country: 2020 VS 2024 VS 2031
5.6.2 Asia Pacific Children's Antipyretic Medicine Sales by Country (2020-2031)
5.6.3 Asia Pacific Children's Antipyretic Medicine Revenue by Country (2020-2031)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Children's Antipyretic Medicine Market Facts & Figures by Country
5.7.1 South America Children's Antipyretic Medicine Market Size by Country: 2020 VS 2024 VS 2031
5.7.2 South America Children's Antipyretic Medicine Sales by Country (2020-2031)
5.7.3 South America Children's Antipyretic Medicine Revenue by Country (2020-2031)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.8 Middle East and Africa Children's Antipyretic Medicine Market Facts & Figures by Country
5.8.1 Middle East and Africa Children's Antipyretic Medicine Market Size by Country: 2020 VS 2024 VS 2031
5.8.2 Middle East and Africa Children's Antipyretic Medicine Sales by Country (2020-2031)
5.8.3 Middle East and Africa Children's Antipyretic Medicine Revenue by Country (2020-2031)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Children's Antipyretic Medicine Sales by Type (2020-2031)
6.1.1 Global Children's Antipyretic Medicine Sales by Type (2020-2031) & (K Units)
6.1.2 Global Children's Antipyretic Medicine Sales Market Share by Type (2020-2031)
6.2 Global Children's Antipyretic Medicine Revenue by Type (2020-2031)
6.2.1 Global Children's Antipyretic Medicine Sales by Type (2020-2031) & (US$ Million)
6.2.2 Global Children's Antipyretic Medicine Revenue Market Share by Type (2020-2031)
6.3 Global Children's Antipyretic Medicine Price by Type (2020-2031)
7 Segment by Application
7.1 Global Children's Antipyretic Medicine Sales by Application (2020-2031)
7.1.1 Global Children's Antipyretic Medicine Sales by Application (2020-2031) & (K Units)
7.1.2 Global Children's Antipyretic Medicine Sales Market Share by Application (2020-2031)
7.2 Global Children's Antipyretic Medicine Revenue by Application (2020-2031)
7.2.1 Global Children's Antipyretic Medicine Sales by Application (2020-2031) & (US$ Million)
7.2.2 Global Children's Antipyretic Medicine Revenue Market Share by Application (2020-2031)
7.3 Global Children's Antipyretic Medicine Price by Application (2020-2031)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Children's Antipyretic Medicine Value Chain Analysis
8.1.1 Children's Antipyretic Medicine Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Children's Antipyretic Medicine Production Mode & Process
8.2 Children's Antipyretic Medicine Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Children's Antipyretic Medicine Distributors
8.2.3 Children's Antipyretic Medicine Customers
9 Global Children's Antipyretic Medicine Analyzing Market Dynamics
9.1 Children's Antipyretic Medicine Industry Trends
9.2 Children's Antipyretic Medicine Industry Drivers
9.3 Children's Antipyretic Medicine Industry Opportunities and Challenges
9.4 Children's Antipyretic Medicine Industry Restraints
10 Report Conclusion
11 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.